Thirumalai Chemicals Limited has informed the Exchange regarding Board meeting held on Jun 19, 2025.
TIRUMALCHM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Thirumalai Chemicals, at its June 19, 2025 meeting, approved raising up to ₹450.63 crores by issuing up to 1,62,68,040 equity shares via preferential allotment at ₹277 per share (a premium of ₹276) to 21 investors. Key investors include Motilal Oswal schemes (Small Cap, Multi Cap, Business Cycle funds), 360 One Equity Opportunity Fund, Bandhan funds, and several HNIs/corporate entities, with Motilal Oswal's combined holding rising to about 6.24% post-issue. The board also approved amending the Articles of Association to allow free transfer of certain debentures, and the pledging of equity shares in wholly owned subsidiary TCL Intermediates Pvt Ltd. CRISIL Ratings was appointed as monitoring agency for the issue proceeds, DAM Capital Advisors acted as sole advisor, and an EGM will be held to seek shareholder approval.
This is a significant equity dilution event — existing shareholders' stakes will reduce once the preferential shares are allotted, though the ₹277 issue price provides a benchmark for valuation. The pledged subsidiary shares and new Article suggest the company may be arranging or preparing for additional debt financing, which shareholders should watch closely post-EGM.